Wednesday, 24 Apr 2019

You are here

An Autoimmune Diagnosis Alters Perceptions of Pregnancy and Lactation

A study from UT Southwestern and the Baylor Research Institute examined the preceptions and practices of women with autoimmune or inflammatory rheumatic diseases (AIRD) noting that an AIRD diagnosis changed most womens future hopes and plans regarding pregnancy and lactation.

This single center registry was based on a survey of 154 AIRD patients who were interviewed regarding fertility, pregnancy, miscarriages, and lactation before and after diagnosis.

More than half  of respondents indicated that their diagnosis negatively changed their views on pregnancy and nearly a third (30%) decided not to have children after AIRD diagnosis.

The majority (66%) women were concerned that medication use during the childbearing process would affect the baby.

One-third (34%) indicated their views on breastfeeding negatively changed as a result of their disease diagnosis.

The rates and duration of breastfeeding did not differ significantly for babies born before or after the mothers’ diagnosis, but 18 women in our study refused breastfeeding or stopped breastfeeding early.

The registry included 19 women who breastfed while being exposed to a DMARD or biologic; none of these reported any developmental delay in their children or increased infection rates.

Disclosures: 
The author has no conflicts of interest to disclose related to this subject

Add new comment

More Like This

Timing of Shoulder Injections Impacts Surgical Infection Risk

A study of patients undergoing arthroscopic rotator cuff repair shows that corticosteroid injections in the month prior to surgery are associated with a significantly increased risk of surgical site infection.

Dietary Supplements Fail to Reduce Mortality Risks

An NIH funded prospective study has shown that the use of daily dietary supplements was not associated with a subsequent lowering of mortality risk.

ACR Position Statements on Drug Pricing and Step Therapy

The American College of Rheumatology Committee on Rheumatologic Care has released new drug pricing and step therapy position statements that they hope legislators will consider as they continue to explore policy and regulatory options to make drugs more affordable and accessible.  

CRA Position Statement on Medical Cannabis Use

Courtesy of the Canadian Rheumatology Association (CRA) website, here are consensus guidelines on medical cannabis use.

Rheumatology patients experience prevalent pain that is only modestly controlled with current treatment strategies.

Senate Drills Drug Makers Over Price

Reuters reported that today, the US Senate Finance Committee met to question the executives from seven US pharmaceutical companies on the rising price drugs in America.